Skip to main content

Table 3 Univariable Cox-regression analysis for clinical parameters as predictors of mortality following coronary intervention

From: Prognostic irrelevance of plaque vulnerability following plaque sealing in high-risk patients with type 2 diabetes: an optical coherence tomography study

 

HR (95% CI)

p

Age (per year)

1.11 (1.04–1.18)

0.001

Sex (male)

0.65 (0.28–1.51)

0.320

ACS at presentation (presence)

0.99 (0.41–2.41)

0.983

CV risk profile

 BMI (per kg/m2)

0.91 (0.82–1.00)

0.059

 Waist circumference (per 10 cm)

0.94 (0.68–1.30)

0.718

 Hypertension (presence)

0.94 (0.28–3.17)

0.923

 Hyperlipidemia (presence)

0.70 (0.30–1.66)

0.704

 Total cholesterol (per 10 mg/dl)

1.05 (0.95–1.16)

0.313

 LDL-c (per 10 mg/dl)

1.07 (0.94–1.21)

0.311

 HDL-c (per 10 mg/dl)

1.43 (1.02–1.99)

0.036

 Triglycerides (per 10 mg/dl)

0.98 (0.92–1.04)

0.447

 Active smoking (presence)

0.99 (0.37–2.66)

0.981

 Pack years (per 10 py)

0.95 (0.79–1.16)

0.637

 Family history of CAD (presence)

0.35 (0.14–0.89)

0.351

 Previous CAD (presence)

1.99 (0.88–4.52)

0.099

 Previous PCI (presence)

1.93 (0.85–4.41)

0.118

 Previous CABG (presence)

2.29 (0.31–17.1)

0.418

 hsCRP (per 10 mg/dl)

1.06 (0.93–1.22)

0.375

 GFR (per 10 mg/dl/1.73 m2)

0.49 (0.27–0.90)

0.020

Other comorbidities

 COPD (presence)

1.30 (0.44–3.48)

0.638

Diabetes severity and therapy

 Diabetes duration (per year)

1.03 (0.99–1.06)

0.125

 Diabetic polyneuropathy (presence)

2.94 (1.29–6.68)

0.010

 Diabetic retinopathy (presence)

1.90 (0.75–4.82)

0.178

 HbA1c (per 1%)

1.34 (0.92–1.97)

0.131

 Insulin (presence)

3.44 (1.45–8.13)

0.005

 Metformin (presence)

0.40 (0.17–0.90)

0.028

 Sulfonylamides (presence)

0.73 (0.25–2.16)

0.575

 Incretins (presence)

2.11 (0.87–5.14)

0.100

Other relevant medication

 Aspirin (presence)

1.21 (0.16–8.96)

0.854

 Statin (presence)

0.54 (0.24–1.24)

0.149

 ACE or ARBi (presence)

0.76 (0.31–1.85)

0.547

 Beta-blocker (presence)

0.52 (0.22–1.24)

0.142

  1. ACS acute coronary syndrome, BMI body mass index, CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, GFR glomerular filtration rate, COPD chronic obstructive pulmonary disease, ACE angiotensin converting enzyme, ARB angiotensin receptor blocker